WebJun 23, 2024 · GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy Clinical Trial Results At 2024 Raymond James Human Health Innovation Conference - read this … WebJun 7, 2024 · Teleflex to Present at the Raymond James 2024 Human Health Innovation Conference. June 07, 2024 06:30 ET Source: Teleflex Incorporated WAYNE, Pa., June 07, …
GT Biopharma Announces Interim GTB-3550 Trike™ Monotherapy …
WebJun 17, 2024 · AUSTIN, Texas, June 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, … WebJun 8, 2024 · AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate … sweatshirt and overalls
Clearside Biomedical to Participate in Two Upcoming
WebJun 18, 2024 · Jun 18, 2024, 07:00 ET. ALPHARETTA, Ga., June 18, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive … WebJun 9, 2024 · Raymond James Human Health Innovations Conference Fireside Chat Wednesday, June 23, 2024 at 8:40 am ET. A link to the live and archived webcasts may be accessed on the Clearside website under the Investors section: Events and Presentations. An archive of the webcast will be available for three months. About Clearside Biomedical WebJun 17, 2024 · AUSTIN, Texas, June 17, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that it has been invited to present at the Raymond James 2024 Human Health Innovation Conference, a virtual event taking place on June 21-23, 2024.. Remi … sweatshirt and matching sweatpants